Researchers have identified follow-up care and outcomes disparities for patients with brain metastasis treated with stereotactic radiosurgery in a private hospital compared with those treated in a safety-net hospital. READ MORE
Scott Glaser, MD, presented results from a study evaluating chemotherapy and radiation therapy in the largest group of patients with stage 2 testicular seminoma ever recorded.
Shorter radiation courses followed by consolidation chemotherapy before surgery may be an effective treatment option for rectal cancer patients.
Roger Longman, MA, offers a perspective on how we can overcome comparative effectiveness research and bring a greater understanding on which drugs work best.
The debate continues to rage over the current cost of cancer care and the value that these drugs bring to patients.
Clinical Pathways in Community Oncology: Assessing the Work of the American Society of Clinical Oncology Task Force on Clinical Pathways
Journal of Clinical Pathways spoke with Robin Zon, MD, FACP, FASCO, chair of ASCO’s Task Force on Clinical Pathways and medical oncologist at Michiana Hematology Oncology, Mishawaka, IN.
Researchers have identified follow-up care and outcomes disparities for patients with brain metastasis treated with stereotactic radiosurgery in a private hospital compared with those treated in a safety-net hospital.
A recent study investigated the drug utilization, health care resource utilization, and disease-related costs among patients with metastatic bladder cancer.
The percentage of US adults under age 65 who skip essential prescription drugs because of price has declined, a five-year study found. But consistently, problems with financial access to medication were more common in cancer survivors.
Chemotherapy drug waste from single-dose vials increased 3-year incremental budget costs by over $100 million in Canada, but is not being modeled uniformly in economic evaluations.
Research in Review
More than 23% of patients with breast cancer who undergo breast-conserving surgery followed by subsequent surgery do not receive the full benefits of surgery due to added costs and complications.
Researchers identified which imaging technique is better for evaluating prognosis of newly-diagnosed multiple myeloma.
Intensified regimens improve event-free survival and overall survival in patients newly diagnosed with diffuse large B-cell lymphoma compared with standard therapy.
A recent analysis reports a cost-effective alternative modality that demonstrates similar efficacy to traditional breast MRI.